Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.
about
Eliminating barriers to personalized medicine: learning from neurofibromatosis type 1A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressorMacrophages: gatekeepers of tissue integrityThe new deal: a potential role for secreted vesicles in innate immunity and tumor progressionIncreased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumorMacrophage polarization in inflammatory diseases.Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain.Molecular and clinical aspects of drug-induced gingival overgrowth.Characterizing newly repopulated microglia in the adult mouse: impacts on animal behavior, cell morphology, and neuroinflammation.Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancerPreclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1.The role of microglia and macrophages in glioma maintenance and progressionDistinct effects of inflammation on preconditioning and regeneration of the adult zebrafish heartDelayed bone regeneration is linked to chronic inflammation in murine muscular dystrophy.Modulation of macrophage activity during fracture repair has differential effects in young adult and elderly mice.An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous systemCancer of the Peripheral Nerve in Neurofibromatosis Type 1.Tumor-associated macrophages and anti-tumor therapies: complex links.The role of the immune system in neurofibromatosis type 1-associated nervous system tumors.Nanomedicine Strategies to Target Tumor-Associated Macrophages.Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs.A Collaborative Model for Accelerating the Discovery and Translation of Cancer Therapies.The synergy between ionizing radiation and immunotherapy in the treatment of prostate cancer.Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors.NF1+/- Hematopoietic Cells Accelerate Malignant Peripheral Nerve Sheath Tumor Development without Altering Chemotherapy Response.Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis.
P2860
Q26828988-72AEBE82-3967-41DE-8877-6DF931D87BE5Q27003534-92777ACA-841E-46CD-A006-9E292C3F74CBQ27007092-FCFD6CBD-296D-42C0-B62D-FEC5C1B4E948Q28084891-78AB2102-83F9-433E-85DB-21425BC4BAE9Q33560776-92326EFE-F41F-4EDB-A84F-62F8A40D6E8EQ33716370-9BAD4607-6B03-4914-B56C-CDADD13CF87FQ34165606-CDA9FD0D-810D-4B8B-A9C4-A8874B0C3034Q34462674-B211F144-A24B-4119-A9A4-8C1600DB228BQ35301791-BB6A61B0-2F36-4424-ACD4-6C22BC3101A8Q35985440-38B938A7-3915-477C-BC8B-4FA2A15180C7Q35987649-17F14B86-D12D-48EE-A747-ED17CBD53599Q36924298-3D83C2DD-AB38-47C9-8CA8-202AD996427EQ37141047-9DA2E3DF-180E-4094-A1B4-6DEFB73D4128Q37484520-4063578D-CB72-4C19-B5E5-94759E3047B0Q37662730-63F1EF99-3EF2-4D9C-A8E8-072712EB9FC1Q37678642-E992D38E-4B7D-4F04-9DFA-17CC753C6715Q38738733-828D8D12-EF71-46E2-8DDD-DB778241F536Q38766176-0B0D9F6F-B204-4FD9-A35E-2798C4B45C47Q39045958-133D435B-9A36-48E6-B205-73AB8E9BBE30Q39283111-E0536FBF-30AE-40A6-8AFF-A7D072D58D36Q40804607-8C9505C0-9E76-4BCE-A243-F91339E0C4CCQ45955739-C7F00FE8-A52A-4C39-B603-087E8F0846A8Q47876974-46970FCB-711D-4A0D-801D-A1DADD30E8D0Q50089792-07700299-D770-405F-98FE-423FA43C181DQ51840300-93396818-8C43-4910-8060-45EFA55A95E4Q52622505-244888AF-FF61-4FD5-9EEE-0189F515A92F
P2860
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Neurofibroma-associated macrop ...... to pharmacological inhibition.
@ast
Neurofibroma-associated macrop ...... to pharmacological inhibition.
@en
type
label
Neurofibroma-associated macrop ...... to pharmacological inhibition.
@ast
Neurofibroma-associated macrop ...... to pharmacological inhibition.
@en
prefLabel
Neurofibroma-associated macrop ...... to pharmacological inhibition.
@ast
Neurofibroma-associated macrop ...... to pharmacological inhibition.
@en
P2093
P2860
P1476
Neurofibroma-associated macrop ...... to pharmacological inhibition.
@en
P2093
Brian L West
Carlos E Prada
Debra A Mayes
Edwin Jousma
Jianqiang Wu
Jose A Cancelas
Nancy Ratner
R Scott Dunn
P2860
P2888
P304
P356
10.1007/S00401-012-1056-7
P577
2012-10-26T00:00:00Z